We estimate that over 60,000 people were able to access cannabis medications for the first time in Europe during 2020, bringing the total to 185,000 patients accessing medical cannabis treatment in the region during the year. Overall, we estimate the value of the market for medical cannabis to be worth €230.7 million as of the end of 2020. Further, we expect the value of European cannabis to grow at a CAGR of 67.4%, to reach €3.2 billion in 2025.
Our exclusive consumer data from over 15,000 adults across seven international markets will allow you to dissect international regulations helping businesses, brands and investors to understand the future of the European cannabis market. Our approach to forecasting the European cannabis industry has its foundation in the database of historical data points (sales, patients, volumes, imports, prices etc.), available in Atalis.